Single fraction radiotherapy is efficacious: a further analysis of the Dutch Bone Metastasis Study controlling for the influence of retreatment

The Dutch Bone Metastasis Study on the effect on painful bone metastases of 8 Gy single fraction (SF) vs. 24 Gy in multiple fractions (MF) showed 24% retreatment after SF vs. 6% after MF ( p < 0.001). The purpose of the present study was to evaluate factors influencing retreatment and its effect...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of radiation oncology, biology, physics biology, physics, 2004-06, Vol.59 (2), p.528-537
Hauptverfasser: van der Linden, Yvette M, Lok, Judith J, Steenland, Elsbeth, Martijn, Hendrik, van Houwelingen, Hans, Marijnen, Corrie A.M, Leer, Jan Willem H
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 537
container_issue 2
container_start_page 528
container_title International journal of radiation oncology, biology, physics
container_volume 59
creator van der Linden, Yvette M
Lok, Judith J
Steenland, Elsbeth
Martijn, Hendrik
van Houwelingen, Hans
Marijnen, Corrie A.M
Leer, Jan Willem H
description The Dutch Bone Metastasis Study on the effect on painful bone metastases of 8 Gy single fraction (SF) vs. 24 Gy in multiple fractions (MF) showed 24% retreatment after SF vs. 6% after MF ( p < 0.001). The purpose of the present study was to evaluate factors influencing retreatment and its effect on response. The database on all randomized patients was reanalyzed with separately calculated responses to initial treatment and retreatment. Response to initial treatment was 71% after SF vs. 73% after MF ( p = 0.84). Retreatment raised response to 75% for SF; MF remained unaltered ( p = 0.54). The response status after initial treatment did not predict occurrence of retreatment: 35% SF vs. 8% MF nonresponders and 22% SF vs. 10% MF patients with progressive pain were retreated. Logistic regression analyses showed the randomization arm and the pain score before retreatment to significantly predict retreatment ( p < 0.001). Retreatment for nonresponders was successful in 66% SF vs. 33% MF patients ( p = 0.13). Retreatment for progression was successful in 70% SF vs. 57% MF patients ( p = 0.24). With or without the effect of retreatment, SF and MF radiotherapy provided equal palliation for painful bone metastases. Irrespective of response to initial treatment, physicians were more willing to retreat after a single fraction. Overall, retreatment was effective in 63% of retreated patients.
doi_str_mv 10.1016/j.ijrobp.2003.10.006
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71932151</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0360301603021102</els_id><sourcerecordid>19414520</sourcerecordid><originalsourceid>FETCH-LOGICAL-c531t-f11984c3e1d90e4f8962a44b09a98f1063ed7d32fcb496a993a9bd5fb463d59a3</originalsourceid><addsrcrecordid>eNqFkc-KFDEQxoMo7rj6BiK56K3HpJPunngQdNd_sOJhFbyF6qTiZuhJZpO0ME-xr2zaGdCTQiBQ9auvku8j5Clna854_3K79tsUx_26ZUzU0pqx_h5Z8c2gGtF13--TFRM9a0SFz8ijnLeMMc4H-ZCc8Y7Ljg9iRe6uffgxIXUJTPEx0ATWx3KDCfYH6jNF57wB4-OcX1Ggbk5Lk0KA6ZBrPzpaC_RyLuaGvo0B6WcskOupzesy2wM1MZQUp6luoi6m37wPbpoxGFwEEpaEUHYYymPywMGU8cnpPiff3r_7evGxufry4dPFm6vGdIKXxnGuNtII5FYxlG6j-hakHJkCtXGc9QLtYEXrzChVD0oJUKPt3Ch7YTsF4py8OOruU7ydMRe989ngNEHA-lU9cCXaatN_Qa5k9bJlFZRH0KSYc0Kn98nvIB00Z3pJTG_1MTG9JLZUa2J17NlJfx53aP8MnSKqwPMTANnAVIMKxue_uEFKNixCr48cVtt-ekw6G784bH1CU7SN_t8v-QVAvrji</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>19414520</pqid></control><display><type>article</type><title>Single fraction radiotherapy is efficacious: a further analysis of the Dutch Bone Metastasis Study controlling for the influence of retreatment</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>van der Linden, Yvette M ; Lok, Judith J ; Steenland, Elsbeth ; Martijn, Hendrik ; van Houwelingen, Hans ; Marijnen, Corrie A.M ; Leer, Jan Willem H</creator><creatorcontrib>van der Linden, Yvette M ; Lok, Judith J ; Steenland, Elsbeth ; Martijn, Hendrik ; van Houwelingen, Hans ; Marijnen, Corrie A.M ; Leer, Jan Willem H ; Dutch Bone Metastasis Study Group</creatorcontrib><description>The Dutch Bone Metastasis Study on the effect on painful bone metastases of 8 Gy single fraction (SF) vs. 24 Gy in multiple fractions (MF) showed 24% retreatment after SF vs. 6% after MF ( p &lt; 0.001). The purpose of the present study was to evaluate factors influencing retreatment and its effect on response. The database on all randomized patients was reanalyzed with separately calculated responses to initial treatment and retreatment. Response to initial treatment was 71% after SF vs. 73% after MF ( p = 0.84). Retreatment raised response to 75% for SF; MF remained unaltered ( p = 0.54). The response status after initial treatment did not predict occurrence of retreatment: 35% SF vs. 8% MF nonresponders and 22% SF vs. 10% MF patients with progressive pain were retreated. Logistic regression analyses showed the randomization arm and the pain score before retreatment to significantly predict retreatment ( p &lt; 0.001). Retreatment for nonresponders was successful in 66% SF vs. 33% MF patients ( p = 0.13). Retreatment for progression was successful in 70% SF vs. 57% MF patients ( p = 0.24). With or without the effect of retreatment, SF and MF radiotherapy provided equal palliation for painful bone metastases. Irrespective of response to initial treatment, physicians were more willing to retreat after a single fraction. Overall, retreatment was effective in 63% of retreated patients.</description><identifier>ISSN: 0360-3016</identifier><identifier>EISSN: 1879-355X</identifier><identifier>DOI: 10.1016/j.ijrobp.2003.10.006</identifier><identifier>PMID: 15145173</identifier><identifier>CODEN: IOBPD3</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Analgesics - therapeutic use ; Biological and medical sciences ; Bone metastases ; Bone Neoplasms - radiotherapy ; Bone Neoplasms - secondary ; Disease Progression ; Female ; Humans ; Logistic Models ; Male ; Medical sciences ; Middle Aged ; Netherlands ; Pain ; Pain - drug therapy ; Pain - etiology ; Pain - radiotherapy ; Pain Measurement ; Proportional Hazards Models ; Radiotherapy ; Radiotherapy Dosage ; Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects) ; Response ; Retreatment ; Technology. Biomaterials. Equipments. Material. Instrumentation ; Time Factors ; Treatment Outcome</subject><ispartof>International journal of radiation oncology, biology, physics, 2004-06, Vol.59 (2), p.528-537</ispartof><rights>2004 Elsevier Inc.</rights><rights>2004 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c531t-f11984c3e1d90e4f8962a44b09a98f1063ed7d32fcb496a993a9bd5fb463d59a3</citedby><cites>FETCH-LOGICAL-c531t-f11984c3e1d90e4f8962a44b09a98f1063ed7d32fcb496a993a9bd5fb463d59a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ijrobp.2003.10.006$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,777,781,3537,27905,27906,45976</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=15744076$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15145173$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>van der Linden, Yvette M</creatorcontrib><creatorcontrib>Lok, Judith J</creatorcontrib><creatorcontrib>Steenland, Elsbeth</creatorcontrib><creatorcontrib>Martijn, Hendrik</creatorcontrib><creatorcontrib>van Houwelingen, Hans</creatorcontrib><creatorcontrib>Marijnen, Corrie A.M</creatorcontrib><creatorcontrib>Leer, Jan Willem H</creatorcontrib><creatorcontrib>Dutch Bone Metastasis Study Group</creatorcontrib><title>Single fraction radiotherapy is efficacious: a further analysis of the Dutch Bone Metastasis Study controlling for the influence of retreatment</title><title>International journal of radiation oncology, biology, physics</title><addtitle>Int J Radiat Oncol Biol Phys</addtitle><description>The Dutch Bone Metastasis Study on the effect on painful bone metastases of 8 Gy single fraction (SF) vs. 24 Gy in multiple fractions (MF) showed 24% retreatment after SF vs. 6% after MF ( p &lt; 0.001). The purpose of the present study was to evaluate factors influencing retreatment and its effect on response. The database on all randomized patients was reanalyzed with separately calculated responses to initial treatment and retreatment. Response to initial treatment was 71% after SF vs. 73% after MF ( p = 0.84). Retreatment raised response to 75% for SF; MF remained unaltered ( p = 0.54). The response status after initial treatment did not predict occurrence of retreatment: 35% SF vs. 8% MF nonresponders and 22% SF vs. 10% MF patients with progressive pain were retreated. Logistic regression analyses showed the randomization arm and the pain score before retreatment to significantly predict retreatment ( p &lt; 0.001). Retreatment for nonresponders was successful in 66% SF vs. 33% MF patients ( p = 0.13). Retreatment for progression was successful in 70% SF vs. 57% MF patients ( p = 0.24). With or without the effect of retreatment, SF and MF radiotherapy provided equal palliation for painful bone metastases. Irrespective of response to initial treatment, physicians were more willing to retreat after a single fraction. Overall, retreatment was effective in 63% of retreated patients.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Analgesics - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Bone metastases</subject><subject>Bone Neoplasms - radiotherapy</subject><subject>Bone Neoplasms - secondary</subject><subject>Disease Progression</subject><subject>Female</subject><subject>Humans</subject><subject>Logistic Models</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Netherlands</subject><subject>Pain</subject><subject>Pain - drug therapy</subject><subject>Pain - etiology</subject><subject>Pain - radiotherapy</subject><subject>Pain Measurement</subject><subject>Proportional Hazards Models</subject><subject>Radiotherapy</subject><subject>Radiotherapy Dosage</subject><subject>Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects)</subject><subject>Response</subject><subject>Retreatment</subject><subject>Technology. Biomaterials. Equipments. Material. Instrumentation</subject><subject>Time Factors</subject><subject>Treatment Outcome</subject><issn>0360-3016</issn><issn>1879-355X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkc-KFDEQxoMo7rj6BiK56K3HpJPunngQdNd_sOJhFbyF6qTiZuhJZpO0ME-xr2zaGdCTQiBQ9auvku8j5Clna854_3K79tsUx_26ZUzU0pqx_h5Z8c2gGtF13--TFRM9a0SFz8ijnLeMMc4H-ZCc8Y7Ljg9iRe6uffgxIXUJTPEx0ATWx3KDCfYH6jNF57wB4-OcX1Ggbk5Lk0KA6ZBrPzpaC_RyLuaGvo0B6WcskOupzesy2wM1MZQUp6luoi6m37wPbpoxGFwEEpaEUHYYymPywMGU8cnpPiff3r_7evGxufry4dPFm6vGdIKXxnGuNtII5FYxlG6j-hakHJkCtXGc9QLtYEXrzChVD0oJUKPt3Ch7YTsF4py8OOruU7ydMRe989ngNEHA-lU9cCXaatN_Qa5k9bJlFZRH0KSYc0Kn98nvIB00Z3pJTG_1MTG9JLZUa2J17NlJfx53aP8MnSKqwPMTANnAVIMKxue_uEFKNixCr48cVtt-ekw6G784bH1CU7SN_t8v-QVAvrji</recordid><startdate>20040601</startdate><enddate>20040601</enddate><creator>van der Linden, Yvette M</creator><creator>Lok, Judith J</creator><creator>Steenland, Elsbeth</creator><creator>Martijn, Hendrik</creator><creator>van Houwelingen, Hans</creator><creator>Marijnen, Corrie A.M</creator><creator>Leer, Jan Willem H</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7X8</scope></search><sort><creationdate>20040601</creationdate><title>Single fraction radiotherapy is efficacious: a further analysis of the Dutch Bone Metastasis Study controlling for the influence of retreatment</title><author>van der Linden, Yvette M ; Lok, Judith J ; Steenland, Elsbeth ; Martijn, Hendrik ; van Houwelingen, Hans ; Marijnen, Corrie A.M ; Leer, Jan Willem H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c531t-f11984c3e1d90e4f8962a44b09a98f1063ed7d32fcb496a993a9bd5fb463d59a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Analgesics - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Bone metastases</topic><topic>Bone Neoplasms - radiotherapy</topic><topic>Bone Neoplasms - secondary</topic><topic>Disease Progression</topic><topic>Female</topic><topic>Humans</topic><topic>Logistic Models</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Netherlands</topic><topic>Pain</topic><topic>Pain - drug therapy</topic><topic>Pain - etiology</topic><topic>Pain - radiotherapy</topic><topic>Pain Measurement</topic><topic>Proportional Hazards Models</topic><topic>Radiotherapy</topic><topic>Radiotherapy Dosage</topic><topic>Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects)</topic><topic>Response</topic><topic>Retreatment</topic><topic>Technology. Biomaterials. Equipments. Material. Instrumentation</topic><topic>Time Factors</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>van der Linden, Yvette M</creatorcontrib><creatorcontrib>Lok, Judith J</creatorcontrib><creatorcontrib>Steenland, Elsbeth</creatorcontrib><creatorcontrib>Martijn, Hendrik</creatorcontrib><creatorcontrib>van Houwelingen, Hans</creatorcontrib><creatorcontrib>Marijnen, Corrie A.M</creatorcontrib><creatorcontrib>Leer, Jan Willem H</creatorcontrib><creatorcontrib>Dutch Bone Metastasis Study Group</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of radiation oncology, biology, physics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>van der Linden, Yvette M</au><au>Lok, Judith J</au><au>Steenland, Elsbeth</au><au>Martijn, Hendrik</au><au>van Houwelingen, Hans</au><au>Marijnen, Corrie A.M</au><au>Leer, Jan Willem H</au><aucorp>Dutch Bone Metastasis Study Group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Single fraction radiotherapy is efficacious: a further analysis of the Dutch Bone Metastasis Study controlling for the influence of retreatment</atitle><jtitle>International journal of radiation oncology, biology, physics</jtitle><addtitle>Int J Radiat Oncol Biol Phys</addtitle><date>2004-06-01</date><risdate>2004</risdate><volume>59</volume><issue>2</issue><spage>528</spage><epage>537</epage><pages>528-537</pages><issn>0360-3016</issn><eissn>1879-355X</eissn><coden>IOBPD3</coden><abstract>The Dutch Bone Metastasis Study on the effect on painful bone metastases of 8 Gy single fraction (SF) vs. 24 Gy in multiple fractions (MF) showed 24% retreatment after SF vs. 6% after MF ( p &lt; 0.001). The purpose of the present study was to evaluate factors influencing retreatment and its effect on response. The database on all randomized patients was reanalyzed with separately calculated responses to initial treatment and retreatment. Response to initial treatment was 71% after SF vs. 73% after MF ( p = 0.84). Retreatment raised response to 75% for SF; MF remained unaltered ( p = 0.54). The response status after initial treatment did not predict occurrence of retreatment: 35% SF vs. 8% MF nonresponders and 22% SF vs. 10% MF patients with progressive pain were retreated. Logistic regression analyses showed the randomization arm and the pain score before retreatment to significantly predict retreatment ( p &lt; 0.001). Retreatment for nonresponders was successful in 66% SF vs. 33% MF patients ( p = 0.13). Retreatment for progression was successful in 70% SF vs. 57% MF patients ( p = 0.24). With or without the effect of retreatment, SF and MF radiotherapy provided equal palliation for painful bone metastases. Irrespective of response to initial treatment, physicians were more willing to retreat after a single fraction. Overall, retreatment was effective in 63% of retreated patients.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>15145173</pmid><doi>10.1016/j.ijrobp.2003.10.006</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0360-3016
ispartof International journal of radiation oncology, biology, physics, 2004-06, Vol.59 (2), p.528-537
issn 0360-3016
1879-355X
language eng
recordid cdi_proquest_miscellaneous_71932151
source MEDLINE; Elsevier ScienceDirect Journals
subjects Adult
Aged
Aged, 80 and over
Analgesics - therapeutic use
Biological and medical sciences
Bone metastases
Bone Neoplasms - radiotherapy
Bone Neoplasms - secondary
Disease Progression
Female
Humans
Logistic Models
Male
Medical sciences
Middle Aged
Netherlands
Pain
Pain - drug therapy
Pain - etiology
Pain - radiotherapy
Pain Measurement
Proportional Hazards Models
Radiotherapy
Radiotherapy Dosage
Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects)
Response
Retreatment
Technology. Biomaterials. Equipments. Material. Instrumentation
Time Factors
Treatment Outcome
title Single fraction radiotherapy is efficacious: a further analysis of the Dutch Bone Metastasis Study controlling for the influence of retreatment
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T16%3A59%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Single%20fraction%20radiotherapy%20is%20efficacious:%20a%20further%20analysis%20of%20the%20Dutch%20Bone%20Metastasis%20Study%20controlling%20for%20the%20influence%20of%20retreatment&rft.jtitle=International%20journal%20of%20radiation%20oncology,%20biology,%20physics&rft.au=van%20der%20Linden,%20Yvette%20M&rft.aucorp=Dutch%20Bone%20Metastasis%20Study%20Group&rft.date=2004-06-01&rft.volume=59&rft.issue=2&rft.spage=528&rft.epage=537&rft.pages=528-537&rft.issn=0360-3016&rft.eissn=1879-355X&rft.coden=IOBPD3&rft_id=info:doi/10.1016/j.ijrobp.2003.10.006&rft_dat=%3Cproquest_cross%3E19414520%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=19414520&rft_id=info:pmid/15145173&rft_els_id=S0360301603021102&rfr_iscdi=true